Abstract

Theophylline (TF) was preferably used for the treatment of asthma and chronic obstructive pulmonary diseases. However, it has a limited therapeutic range. So the controlled release of theophylline is required. In this study, TF was encapsulated with poly (vinyl alcohol) (PVA) and sodium carboxy methyl cellulose (NaCMC) polymers by using ionic gelation and liquid ripening method and iron III chloride (FeCl3) was used as crosslinking agent. Prepared microspheres were characterized and also defined by equilibrium swelling values and release profiles. Microspheres, in which the most suitable release conditions were determined, coated with EC and drug release studies were carried out.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.